首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Detection of Human Kallikrein 4 in Healthy and Cancerous Prostatic Tissues by Immunofluorometry and Immunohistochemistry
【24h】

Detection of Human Kallikrein 4 in Healthy and Cancerous Prostatic Tissues by Immunofluorometry and Immunohistochemistry

机译:免疫荧光法和免疫组织化学法检测健康和癌性前列腺组织中人激肽释放酶4

获取原文
           

摘要

Background: Human kallikrein 4 (gene, KLK4 ; protein, hK4), a recently discovered member of the kallikrein gene family, shares many characteristics with prostate-specific antigen, the best available marker for prostate cancer. Because the protein has not been detected in any human tissue, we attempted to develop immunologic methods for hK4 analysis and use them to detect hK4 in healthy and cancerous tissue extracts and biological fluids.Methods: We extracted total RNA from 20 pairs of matched (healthy–cancer) prostate tissue samples. KLK4 cDNA was amplified by reverse transcription-PCR (RT-PCR) and cloned in a pPICZαA expression vector. We then transformed the construct product into Pichia pastoris yeast strains and induced secreted recombinant protein production by addition of methanol. We purified the recombinant protein by nickel ion-affinity chromatography and used it as an immunogen in rabbits and mice to generate polyclonal anti-hK4 antibodies. These antibodies were used to develop a sandwich-type immunoassay suitable for hK4 quantification in biological fluids and tissue extracts.Results: The immunoassay had a detection limit of 0.1 μg/L. We detected hK4 in 10 of 21 matched (healthy–cancer) prostate tissues, and hK4 was frequently higher in healthy tissues. In one matched-sample pair, the hK4 content was relatively high in both the healthy [4.62 μg/g of total protein (TP)] and the cancerous (1.22 μg/g of TP) prostate tissue. Among tissue extracts, we found the highest concentrations of hK4 in healthy (0.0–4.62 μg/g of TP) and cancerous (0.0–1.72 μg/g of TP) prostatic extracts and in placental extracts (0.0–0.05 μg/g of TP). We also detected traces of hK4 protein immunoreactivity in amniotic fluid (0.1–0.6 μg/L), human breast milk (0.1–0.75 μg/L), and seminal plasma (0.2–0.9 μg/L). Immunohistochemical studies showed cytoplasmic staining for hK4 protein in both malignant and benign epithelial cells of the prostate. However, we did not detect hK4 in cerebrospinal fluid, healthy and cancerous ovarian tissue extracts, and many other human tissue extracts.Conclusions: hK4 protein is present in some prostatic tissue extracts but at relatively low concentrations, although KLK4 mRNA is readily detectable by RT-PCR. We propose that the protein either is not synthesized efficiently or is degraded very quickly.
机译:背景:人类激肽释放酶4(基因,KLK4;蛋白质,hK4)是激肽释放酶基因家族的最新成员,与前列腺特异性抗原(前列腺癌的最佳可用标志物)具有许多特性。由于尚未在任何人体组织中检测到该蛋白,因此我们尝试开发免疫学方法进行hK4分析,并将其用于检测健康和癌性组织提取物和生物体液中的hK4。方法:我们从20对匹配的(健康的–癌)前列腺组织样本。通过逆转录PCR(RT-PCR)扩增KLK4 cDNA,并将其克隆到pPICZαA表达载体中。然后,我们将构建产物转化为巴斯德毕赤酵母菌株,并通过添加甲醇诱导分泌的重组蛋白生产。我们通过镍离子亲和层析纯化了重组蛋白,并将其用作兔和小鼠的免疫原,以产生多克隆抗hK4抗体。这些抗体被用于开发适用于生物体液和组织提取物中hK4定量的夹心型免疫分析法。结果:该免疫分析法的检出限为0.1μg/ L。我们在21个匹配的(健康癌)前列腺组织中检测出10个hK4,而在健康组织中hK4经常更高。在一对匹配的样本中,健康的前列腺组织(4.62μg/ g的总蛋白质(TP))和癌的前列腺组织(1.22μg/ g的总hh4含量)都相对较高。在组织提取物中,我们发现在健康的前列腺提取物中(0.0–4.62μg/ g TP)和癌性(0.0–1.72μg/ g TP)和胎盘提取物中的hK4浓度最高(TP的0.0–0.05μg/ g )。我们还检测到羊水(<0.1–0.6μg/ L),人母乳(<0.1–0.75μg/ L)和精浆(0.2–0.9μg/ L)中的hK4蛋白免疫反应痕迹。免疫组织化学研究显示前列腺癌和良性上皮细胞中hK4蛋白的细胞质染色。然而,我们并未在脑脊液,健康和癌性卵巢组织提取物中以及许多其他人体组织提取物中检测到hK4。结论:尽管一些KLK4 mRNA可以通过RT轻松检测到,但某些前列腺组织提取物中仍存在hK4蛋白。 -PCR。我们建议该蛋白质不是有效地合成或被很快降解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号